Betta Pharmaceuticals Co., Ltd. (SZSE: 300558)
Health Care · Pharmaceuticals · CN
CN¥50.48
+4.67% today · -26.3% 1Y
Betta Pharmaceuticals Co., Ltd. (SZSE: 300558) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $3.17B and employs 1,785 people.
Over the last twelve months the share price has lost 26.3%, trading between 40.10 and 78.18.
Tweenvest scores Betta Pharmaceuticals Co., Ltd. across four factors: quality 70/100, value 71/100, growth 42/100, dividend 9/100. Its strongest factor is value.
300558 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $3.17B
- Revenue (TTM)
- $567.34M
- P/E
- 45.24
- EPS
- 1.12
- Dividend yield
- 0.30%
- Beta (5Y)
- 0.52
- 52-week high
- CN¥78.18
- 52-week low
- CN¥40.10
- Avg volume (3M)
- —
- Shares outstanding
- 420.73M
- Employees
- 1,785
- Next earnings
- —
About Betta Pharmaceuticals Co., Ltd.
Betta Pharmaceuticals Co., Ltd. is a Chinese pharmaceutical company dedicated to the discovery, development, manufacturing, and commercialization of oncology treatments. Among its key offerings are Icotinib hydrochloride, an orally taken epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor, and Ensartinib hydrochloride, an anaplastic lymphoma kinase (ALK) inhibitor, both utilized in the management of non-small-cell lung cancer. Founded in 2003, the firm is headquartered in Hangzhou, China.
- ISIN
- CNE100002DD9
- Founded
- 2003
- Listed since
- Nov 9, 2016
- Exchange
- Shenzhen Stock Exchange
- Currency
- CNY
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Santen Pharmaceutical Co., Ltd.TSE: 4536 | $3.35B | ¥1,645.50 | -5.89% |
| Laboratorios Farmaceuticos Rovi, S.A.BME: ROVI | $3.33B | €58.15 | -1.44% |
| China Medical System Holdings LimitedSEHK: 867 | $3.24B | HK$10.44 | -1.97% |
| Tarsus Pharmaceuticals, Inc.NasdaqGS: TARS | $3.20B | $72.22 | -1.07% |
| Hybio Pharmaceutical Co., Ltd.SZSE: 300199 | $3.15B | CN¥23.92 | +2.66% |
| Hebei Changshan Biochemical Pharmaceutical Co., Ltd.SZSE: 300255 | $3.14B | CN¥22.94 | -0.74% |
| Tasly Pharmaceutical Group Co., LtdSHSE: 600535 | $3.12B | CN¥14.00 | +2.34% |
| Sunshine Lake Pharma Co., Ltd.SEHK: 6887 | $3.09B | HK$42.12 | +6.36% |
Figures last refreshed Oct 4, 2026.